Further studies have revealed that SNORD113-1 attenuates the phosphorylation of SMAD2/3 and ERK1/2 in the ERK/MAPK and TGF-β pathways, thus inhibiting tumorigenesis in HCC. Here, MAPK3 is linked to hepatocellular carcinoma.